CN119236005A - 一种治疗骨关节炎的中药组合物及其应用 - Google Patents
一种治疗骨关节炎的中药组合物及其应用 Download PDFInfo
- Publication number
- CN119236005A CN119236005A CN202411445371.0A CN202411445371A CN119236005A CN 119236005 A CN119236005 A CN 119236005A CN 202411445371 A CN202411445371 A CN 202411445371A CN 119236005 A CN119236005 A CN 119236005A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- chinese medicine
- blood
- blood stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 239000008280 blood Substances 0.000 claims abstract description 83
- 210000004369 blood Anatomy 0.000 claims abstract description 81
- 239000004863 Frankincense Substances 0.000 claims abstract description 21
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 12
- 239000008159 sesame oil Substances 0.000 claims abstract description 12
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 12
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 11
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 9
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 8
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000972672 Phellodendron Species 0.000 claims abstract description 3
- 238000001816 cooling Methods 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 241000563984 Ampelopsis Species 0.000 claims description 9
- 241001313857 Bletilla striata Species 0.000 claims description 9
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 240000004980 Rheum officinale Species 0.000 claims description 7
- 235000008081 Rheum officinale Nutrition 0.000 claims description 7
- 241000037740 Coptis chinensis Species 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 241000972673 Phellodendron amurense Species 0.000 claims description 4
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 241000123835 Ampelopsis japonica Species 0.000 claims description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 claims description 2
- 230000036407 pain Effects 0.000 abstract description 48
- 208000002193 Pain Diseases 0.000 abstract description 47
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 230000008961 swelling Effects 0.000 abstract description 14
- 208000014674 injury Diseases 0.000 abstract description 11
- 230000007774 longterm Effects 0.000 abstract description 7
- 230000008733 trauma Effects 0.000 abstract description 7
- 230000017423 tissue regeneration Effects 0.000 abstract description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 206010041956 Stasis syndrome Diseases 0.000 abstract description 2
- 208000005634 blind loop syndrome Diseases 0.000 abstract description 2
- 241001313855 Bletilla Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 241000246044 Sophora flavescens Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 38
- 238000011282 treatment Methods 0.000 description 23
- 208000006820 Arthralgia Diseases 0.000 description 19
- 239000002674 ointment Substances 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 17
- 229940079593 drug Drugs 0.000 description 15
- 241000717739 Boswellia sacra Species 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 238000003745 diagnosis Methods 0.000 description 11
- 241001057584 Myrrha Species 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 210000002435 tendon Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 210000003127 knee Anatomy 0.000 description 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 210000001503 joint Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 208000034783 hypoesthesia Diseases 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010023232 Joint swelling Diseases 0.000 description 3
- 241000219061 Rheum Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000008558 Osteophyte Diseases 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000307 commiphora myrrha gum Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000005786 degenerative changes Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 208000024764 elbow pain Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000009916 joint effect Effects 0.000 description 2
- 230000008407 joint function Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000036487 Arthropathies Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 201000011275 Epicondylitis Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010018634 Gouty Arthritis Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000001555 commiphora myrrha gum extract Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 201000011666 conjunctival pterygium Diseases 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- MPOKJOWFCMDRKP-UHFFFAOYSA-N gold;hydrate Chemical compound O.[Au] MPOKJOWFCMDRKP-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗骨关节炎的中药组合物及其应用。其按重量份数计包含以下原料制备得到:大黄30重量份、黄柏30重量份、黄芩30重量份、黄连30重量份、白芨30重量份、白蔹30重量份、白芷30重量份、苦参30重量份、乳香15重量份、没药15重量份、香油100重量份。该中药组合物能够调理气血、疏通经络、活血化瘀、清热燥湿、消肿生肌止痛,适用于外伤或湿热引起的气滞血瘀证型的骨关节炎患者,尤其适用于长时间反复发作且难以根治的患者,在治疗骨关节炎方面具有较高的临床应用价值。
Description
技术领域
本发明属于中药技术领域,具体涉及一种治疗骨关节炎的中药组合物及其应用。
背景技术
骨关节炎是一类发病率较高、严重影响患者生活质量的疾病,尤其在中老年人群和体力劳动者中较为常见。骨关节炎属于中医“痹病”范畴。“痹病”一词首见于《扁鹊心书·痹病》:“风寒湿气合而为痹,走注疼痛,或臂腰足膝拘挛,两肘牵急,乃寒邪凑于分肉之间也......痹者,气血凝滞而不行,留滞于五脏之外,合而为病”。《素问·痹论篇》所言“风、寒、湿三气杂至,合而为痹也”。由此可见,痹则不通,乃有形之实邪所致;无论膝痹病机的虚与实,都存在实邪。
中医理论认为,骨关节炎的病因复杂多样,包括外感风寒湿邪、跌打损伤、劳损过度及先天体质虚弱等。依据骨痹(骨关节炎)中医诊疗方案(2017年版),可将骨痹分为肝肾亏虚证、寒湿痹阻证、湿热阻络证、痰瘀互结证、气血两虚证5个证型。通过长期临床工作发现外伤或湿热引起的气滞血瘀也是导致骨关节炎的常见病理机制之一。《玉机》云“打扑金刃损伤……必有瘀血”,《素问》云“气伤痛,形伤肿”。气本无形,血有形,形伤肿,使无形之气聚集于患处,胜似有形。气滞血瘀,导致经络不通,不通则痛。炎症与中医的湿热邪气对应,热邪在体内煎灼血液,湿邪阻滞气机,致气机郁滞。“气为血之帅,血为气之母”,气滞则血行不畅,瘀血停滞在经络、关节,不通则通,进而引发疼痛。若气滞血瘀日久,瘀血阻滞易郁而化热,湿热邪气与气血搏结,故而产生红肿。外伤或湿热引起的气滞血瘀证型的骨关节炎,主要表现为疼痛部位固定,痛如针刺,尤其在夜间疼痛加重,局部伴有红肿,活动不利,且触碰时疼痛感明显加剧。目前临床对于气滞血瘀证型的骨关节炎缺乏相对应的中医治疗方案。
在现代医学中,气滞血瘀型骨关节炎对应的临床表现往往伴有关节炎症、软组织损伤、局部血流不畅等。西医通常通过非甾体抗炎药(NSAIDs)、类固醇药物或物理疗法如热疗、按摩等来缓解症状。这些治疗方法尽管在短期内能够减轻疼痛,但长期使用非甾体抗炎药和类固醇类药物会带来消化系统、心血管系统及肾脏等方面的不良反应。同时,西医的治疗更多关注症状的缓解,而无法从根本上解决病因。因此,许多患者的疼痛症状在治疗后仍反复发作,无法得到彻底的缓解。
与西医的对症治疗相比,中医药治疗骨关节炎尤其在气滞血瘀型病症方面,具有独特的优势。《素问》云:“宗筋主束骨而利机关也”。筋附骨,骨连筋,肌筋在外,骨在内。中医强调辨证施治,通过调理气血、疏通经络、活血化瘀、清热燥湿、消肿生肌止痛等手段,治疗气滞血瘀型骨关节炎能够改善患者的病情。目前,临床中常用的中药方剂如活血化瘀类药物(如川芎、丹参、红花等)在缓解关节痛方面已有一定成效。然而,传统中药方剂多以经验为基础,药物配伍不够精准,且疗效因人而异,仍存在一些不足。例如,部分方剂缺乏针对性,无法有效改善气滞血瘀导致的疼痛和功能障碍。此外,现有的中药外用疗法,如药油等,虽然具有较好的局部治疗作用,但在药效持续性和安全性方面仍需进一步改进。
发明内容
本发明提出了一种专门用于治疗气滞血瘀型骨关节炎的中药组合物(筋骨肿痛宁),通过精准的药物配伍及应用,旨在有效缓解由于气滞血瘀所导致的四肢关节疼痛、肿胀、功能障碍等症状,该组合物能够调理气血、疏通经络、活血化瘀、清热燥湿、消肿生肌止痛,适用于外伤或湿热引起的气滞血瘀证型的骨关节炎患者,尤其适用于长时间反复发作且难以根治的患者。本发明提供了一种在中医理论与现代药理研究基础上的创新治疗方法。
本发明提供一种治疗气滞血瘀型骨关节炎的中药组合物,所述中药组合物按重量份数计由以下原料制备得到:大黄20-40重量份、黄柏20-40重量份、黄芩20-40重量份、黄连20-40重量份、白芨20-40重量份、白蔹20-40重量份、白芷20-40重量份、苦参20-40重量份、乳香10-20重量份、没药10-20重量份、香油80-120重量份。
所述治疗气滞血瘀型骨关节炎的中药组合物,所述中药组合物按重量份数计由以下原料制备得到:大黄30重量份、黄柏30重量份、黄芩30重量份、黄连30重量份、白芨30重量份、白蔹30重量份、白芷30重量份、苦参30重量份、乳香15重量份、没药15重量份、香油100重量份。
所述的中药组合物,制备方法包括:
步骤一:将大黄、黄柏、黄芩、黄连、白芨、白蔹、白芷、苦参粉碎成细末,备用;
步骤二:将香油加热至120℃,慢火炸没药和乳香至药材呈金黄色,过滤去渣;
步骤三:将步骤一得到的药粉与步骤二中的药油混合,搅拌均匀,制成膏状,冷却后密封保存备用。
所述的中药组合物在制备治疗气滞血瘀型骨关节炎药物中的应用。
将混合好的药膏冷却至室温,盛装于密闭容器中,密封保存,备用。药膏需避免光照、高温和潮湿环境,以保证药效稳定。
所述中药组合物可制备为外用药膏,直接涂抹于疼痛部位,每日1次,每次涂抹后适当按摩促进吸收。
使用方法:每日将适量药膏涂抹于患处,每次按摩5-10分钟,以促进药物吸收。连续使用2至4周,症状明显改善。
本发明遵循中医辨证论治原则由《正体类要》中“万金膏”化裁而来。上述各味中药的入经、功能、主治和作用原理如下:具有调理气血、疏通经络、活血化瘀、清热燥湿、消肿生肌止痛的功效,能够促进气血流通,解除瘀阻,祛除湿邪,促进关节周围组织再生,恢复关节正常功能。
大黄:味苦,性寒,归脾、胃、大肠、肝、心经。《神农本草经》:“主下瘀血,下闭,寒热,破癥瘕积聚,留饮宿食,荡涤肠胃,推陈致新,通利水谷道,调中化食,安和五脏。”《景岳全书》:“涤实痰,导瘀血,通水道,退湿热,开燥结。”作为君药,大黄直入血分,具有强大的活血化瘀、逐瘀血下行的功效,同时大黄还具有清热泻下之功,能够引热下行。在本方中对于促进瘀血化解,清解湿热起到主要的作用。
黄柏:味苦,性寒,归肾、膀胱、大肠经。《药性赋》:“泻下焦隐伏之龙火,安上焦虚哕之蛔虫,脐下痛单制而能除,肾不足生用而能补,痿厥除湿药中不可缺。”黄芩:味苦,性寒,归肺、胃、胆、大肠经。《医学启源》:"黄芩,治肺中湿热,疗上热目中肿赤,瘀血壅盛,必用之药。黄连:味苦,性寒,归心、肝、胃、大肠经。《珍珠囊》:“其用有六:泻心火,一也;去中焦湿热,二也;诸疮必用,三也;去风湿,四也;治赤眼暴发,五也;止中部见血,六也。”三者作为臣药共同协作,能够清上、中、下三焦湿热,苦寒降火,特别适用于湿热引起气滞血瘀导致的关节肿胀、疼痛,能够有效缓解局部炎症反应,减轻红肿热痛等症状。同时辅助大黄之药,增强清热凉血、消肿止痛之效。
白芨:味苦,性寒,归肺、胃、肝经。《本草经百种录》:“白芨,气味冲淡和平,而体质滑润,又极粘腻,入于筋骨之中,能和柔滋养,与正气相调,则微邪自退也。”使大黄等活血药活血而不过其极。白蔹:味苦,性微寒,归心、胃经。《本草正义》:“于《本经》、《别录》之外,多一层凉血破血,化瘀生新之义。”白芷:味辛,性温,归肺、胃经。《日华子本草》:“治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢。”能入冲脉。致阳明之气于冲脉,调冲脉之血而随阳明,去阳明之浊翳,致冲脉之清和。作为佐药,这些药物具有良好的消肿生肌止痛、活血化瘀的功效,能够促进软组织修复,减轻局部疼痛和肿胀。同时,这些药物对加速组织再生、促进血液循环有积极作用,尤其适合气滞血瘀型骨关节炎患者。
苦参:味苦,性寒,归心、肝、胃、大肠、膀胱经。作为使药具有清热燥湿、祛风止痛的作用,适用于关节疼痛伴随的麻木感和僵硬感。乳香:味辛、苦,性温,归心、肝、脾经。乃树之血液,其色黄白透明,得木气而兼火化。气香窜,故善透窍以理气,于十二经络无所不入,阳也,升也,透也散也。以其似人身之血液,故可入脾、肺、心、肝、肾五脏,能辟邪恶诸气,能使气与血互相通活,俾气不令血阻、血亦不被气碍,气血和合而能令真气滋生;又凡人筋不伸者,敷药宜加乳香,其性能伸筋。没药:味辛、苦,性平,归心、肝、脾经。亦树之津液,其色褐,正如血液之色,禀金水之气以生,阴也,降也,宣散也。《本草新编》:“消肿突恶疮、痈疽溃腐,破血止痛如神,疗坠堕跌打损伤尤效”《本草纲目》:“乳香活血,没药散血,皆能止痛、消肿、生肌,故二药每每相兼而用。”这两位药相辅相成,一者最善理气,一者最善行瘀,气血并治,具有活血化瘀、行气止痛的功效。作为使药,引导上述各药发挥所长,通血脉、散瘀血。
香油:作为药物的载体,香油不仅能够提高药物的渗透性,还具有滋润肌肤的作用,同时为药材成分提供了一个良好的溶媒环境,增强药物的局部吸收效果。
各种药材在该组合物中的配伍具有严格的原则,既体现了中医的“君臣佐使”配伍思想,又结合了现代医学对于药物的具体功能研究:
大黄:具有提高血浆渗透压,使组织血分向血管内转移,降低血液粘度,促进血液循环。大黄中的大黄素甲醚通过抑制TGF-β/NF-κB/MAPK通路,调节炎性细胞因子的表达,从而达到治疗关节炎的作用。
黄芩、黄柏、黄连:具有抗炎、抗氧化、抗菌作用。
白芨、白蔹、白芷:具有抗炎、抗氧化、镇痛和保护软骨作用。
苦参、乳香、没药:苦参能起到免疫抑制、抗局部皮肤过敏的作用,使本发明更好的适用于患病人群。乳香含乳香素,入血能增加多核白细胞,以攻坚破瘀,减轻炎症。没药含有没药油、树脂、树胶等,能防腐生机,抗炎消肿。乳香和没药阻断了免疫细胞释放与疼痛有关的炎症因子,起到末梢性止痛的作用。
所述中药组合物特别适用于气滞血瘀型骨关节炎患者,能够缓解以下症状:疼痛部位固定,痛如针刺,活动不利,尤其在夜间加重,疼痛部位按压时痛感加剧,局部红肿。尤其适用于长期反复发作的气滞血瘀型关节痛患者,通过持续使用可以缓解疼痛、改善关节功能,减少复发的可能性。
该组合物通过外用方式应用,避免了口服药物带来的消化道不良反应,具有高安全性和较好的患者依从性。
本发明的中药组合物经过临床试验验证,显示其对气滞血瘀型关节痛的疗效显著。试验中,患者通过连续使用本组合物的药膏,疼痛明显减轻,关节活动度提高,日常生活质量得到明显改善。尤其对于那些长期使用非甾体抗炎药但疗效不佳的患者,本发明提供了一种有效的替代疗法,安全性更高,副作用更少。
本发明不仅在传统中医理论上具有坚实的基础,还结合现代药理学的研究成果和长期临床实践,证明其在调理气血、疏通经络、活血化瘀、清热燥湿、消肿生肌止痛方面的作用。本发明的制备工艺简单,原料易得,成本低廉,适合大规模推广应用。该中药组合物为气滞血瘀型骨关节炎的患者提供了一个安全、有效的治疗选择,具有广泛的临床应用前景。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面对本发明实施例的技术方案进行清楚、完整地描述。显然,所描述的实施例是本发明的一部分实施例,而不是全部的实施例。基于所描述的本发明的实施例,本领域普通技术人员在无需创造性劳动的前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1:取大黄30g、黄柏30g、黄芩30g、黄连30g、白芨30g、白蔹30g、白芷30g、苦参30g、乳香15g、没药15g、香油100g,制备步骤如下:①药材粉碎:将大黄、黄柏、黄芩、黄连、白芨、白蔹、白芷、苦参粉碎成细末,过筛备用。②香油处理:取100g香油,放入容器中加热至120℃,保持恒温,加入乳香和没药,继续加热并搅拌,直到乳香和没药的药效充分释放,油体呈现金黄色为止,过滤去渣,留下药油备用。③混合搅拌:将步骤1得到的药材粉末与步骤2中的药油充分混合,搅拌均匀,直至形成均匀的膏状物。④冷却和包装:将混合好的药膏冷却至室温,盛装于密闭容器中,密封保存,备用。药膏需避免光照、高温和潮湿环境,以保证药效稳定。
实施例2:取大黄20g、黄柏40g、黄芩20g、黄连40g、白芨20g、白蔹40g、白芷20g、苦参40g、乳香10g、没药20g、香油80g,制备步骤如下:①药材粉碎:将大黄、黄柏、黄芩、黄连、白芨、白蔹、白芷、苦参粉碎成细末,过筛备用。②香油处理:取100g香油,放入容器中加热至120℃,保持恒温,加入乳香和没药,继续加热并搅拌,直到乳香和没药的药效充分释放,油体呈现金黄色为止,过滤去渣,留下药油备用。③混合搅拌:将步骤1得到的药材粉末与步骤2中的药油充分混合,搅拌均匀,直至形成均匀的膏状物。④冷却和包装:将混合好的药膏冷却至室温,盛装于密闭容器中,密封保存,备用。药膏需避免光照、高温和潮湿环境,以保证药效稳定。
实施例3:取大黄40g、黄柏20g、黄芩40g、黄连20g、白芨40g、白蔹20g、白芷40g、苦参20g、乳香20g、没药10g、香油120g,制备步骤如下:①药材粉碎:将大黄、黄柏、黄芩、黄连、白芨、白蔹、白芷、苦参粉碎成细末,过筛备用。②香油处理:取100重量份香油,放入容器中加热至120℃,保持恒温,加入乳香和没药,继续加热并搅拌,直到乳香和没药的药效充分释放,油体呈现金黄色为止,过滤去渣,留下药油备用。③混合搅拌:将步骤1得到的药材粉末与步骤2中的药油充分混合,搅拌均匀,直至形成均匀的膏状物。④冷却和包装:将混合好的药膏冷却至室温,盛装于密闭容器中,密封保存,备用。药膏需避免光照、高温和潮湿环境,以保证药效稳定。
实施例4:临床研究
本临床研究病例选择2024年1月-2024年8月来源于苏州市中医医院骨伤科气滞血瘀型骨关节炎患者,符合纳入和排除标准,且患者同意参加本次临床观察,共收集50例,应用由本发明的中药组合物制得的中药膏剂进行治疗,观察中医症状及相关体征评分相关指标。
1.诊断及纳入标准
1.1西医诊断标准参照《骨关节炎诊疗指南(2018年版)》中骨关节炎的诊断标准拟定以下标准:①多数患者有慢性劳损外伤;②常发生于中老年;③慢性、逐渐加重的关节疼痛,通常伴随活动后加重,休息后缓解;④晨僵(关节僵硬)时间通常不超过30分钟;⑤关节活动范围受限,关节肿胀和压痛,特别是膝关节、髋关节、手指关节等负重关节;⑥影像学检查:关节X线检查常见的特征包括关节间隙变窄、骨赘形成、软骨下骨硬化及囊变。在晚期病例中,可能看到关节畸形和软骨的广泛退行性改变;⑦实验室检查:骨关节炎的实验室检查通常无特异性,血常规、血清等炎症指标一般正常。
1.2中医诊断标准:参照《中医病证诊断疗效标准》及《国际血瘀证诊断指南》中气滞血瘀证诊断标准:曾有外伤史,关节刺痛、掣痛,或疼痛较剧,痛有定处。或伴肢体麻木,关节及周围可见瘀色。舌质紫暗或有瘀点、瘀斑,舌苔白腻,脉弦或涩。
1.3病例纳入标准:①年龄在35岁至80岁之间,性别不限;②确诊为气滞血瘀型骨关节炎;③近3个月内未接受其他相关治疗(如激素类药物、非甾体抗炎药的长期使用);④自愿参与本研究,并签署知情同意书。
1.4病例排除标准:①合并其他严重疾病,如类风湿性关节炎、痛风性关节炎等;②合并严重心血管疾病、肝肾功能不全或肿瘤史;③妊娠期或哺乳期妇女;④有严重的皮肤过敏史或对中药成分过敏者;⑤精神疾病或不能配合试验的患者。
1.5病例的脱落及剔除标准:①受试者依从性差,不能坚持治疗者;②发生了较为严重不良反应,如出现神经功能的异常等;③临床试验过程中出现较为严重的其它疾病者;④使用本治疗有效,但加用其他治疗方法,无法判定疗效者。
2.评价指标
两周、四周后观察疗效,主要观察第14、28天患者VAS评分、骨关节炎指数(WOMAC)和关节活动度情况。疗效评定:依据《骨关节炎诊治指南》制定的疗效标准,评估患者治疗后的临床疗效,将疗效分为以下几类:
痊愈:疼痛消失,关节活动度恢复正常,日常活动能力恢复,WOMAC评分降低80%以上;显效:疼痛显著缓解,关节活动度明显改善,WOMAC评分降低50%-80%;有效:疼痛有所缓解,关节功能有所改善,WOMAC评分降低20%-50%;无效:治疗前后症状无明显改善,WOMAC评分降低不到20%。疗效指数=(治疗前VAS评分-治疗后VAS评分)/治疗前VAS评分×100%。
结果:给予上述50例气滞血瘀型骨关节炎患者就诊后第一天即开始涂擦由本发明实施例1制备的中药膏剂,每日将适量药膏涂抹于患处,每次按摩5至10分钟,以促进药物吸收,连续使用2至4周。结果显示中医证候疗效痊愈5例,显效22例,有效15,无效8例,总有效率为84%。
3.典型病例
病例1:陈某,女性,苏州市中医医院,门诊号:G709155572。主因“左肘疼痛不适2月”就诊。患者2月前无明显诱因下出现左肘关节疼痛不适,活动稍受限,拎重物时疼痛加重,夜间疼痛明显,无明显外伤史,无上臂麻木,遂来我院就诊,病程中患者纳寐可,二便调,舌质紫暗,苔白腻,脉弦。查体:左肱骨外上髁压痛叩击痛,旋转活动受限,肱二头肌肌腱、肱三头肌肌腱反射存在。查右肘X片示:左肘退行性改变。诊断为左肘骨关节炎,中医诊断为骨痹-气滞血瘀证,给予本发明实施例1制备的中药膏剂涂擦,每日1次,每次按摩5-10分钟,治疗14天。治疗后患者左肘疼痛及活动度明显好转,继续予上述方案治疗,28天后复查上述症状完全消失。
病例2:孙某,女性,苏州市中医医院,门诊号:G706670654。主因“左膝疼痛伴活动不利1月余”就诊。患者1月余前无明显诱因下出现左膝关节疼痛不适,活动受限,久站后疼痛加重,不能长时间行动,上下楼梯困难,夜间疼痛明显,无明显外伤史,无下肢麻木,遂来我院就诊,病程中患者纳寐一般,二便调,舌质紫暗,苔白腻,脉弦。查体:左膝外观轻度红肿,局部压痛阳性,以内侧为甚,侧方试验、抽屉试验(-),过伸过屈试验(+),膝关节活动度0~90°。查左膝X片示:左膝关节周围骨赘形成。诊断为左膝骨关节炎,中医诊断为骨痹-气滞血瘀证,给予本发明实施例1制备的中药膏剂涂擦,每日1次,每次按摩5-10分钟,治疗14天。治疗后患者左膝疼痛及活动度明显好转,继续予上述方案治疗,28天后复查上述症状完全消失。
综上所述,本发明中治疗骨关节炎的中药组合物用于治疗由气滞血瘀导致的骨关节炎具有活血化瘀和行气止痛的效果,中医临床症状明显改善。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。
Claims (4)
1.一种治疗气滞血瘀型骨关节炎的中药组合物,其特征在于,所述中药组合物按重量份数计由以下原料制备得到:大黄20-40重量份、黄柏20-40重量份、黄芩20-40重量份、黄连20-40重量份、白芨20-40重量份、白蔹20-40重量份、白芷20-40重量份、苦参20-40重量份、乳香10-20重量份、没药10-20重量份、香油80-120重量份。
2.根据权利要求1所述一种治疗气滞血瘀型骨关节炎的中药组合物,其特征在于,所述中药组合物按重量份数计由以下原料制备得到:大黄30重量份、黄柏30重量份、黄芩30重量份、黄连30重量份、白芨30重量份、白蔹30重量份、白芷30重量份、苦参30重量份、乳香15重量份、没药15重量份、香油100重量份。
3.根据权利要求1所述的中药组合物,其特征在于,制备方法包括:
步骤一:将大黄、黄柏、黄芩、黄连、白芨、白蔹、白芷、苦参粉碎成细末,备用;
步骤二:将香油加热至120℃,慢火炸没药和乳香至药材呈金黄色,过滤去渣;
步骤三:将步骤一得到的药粉与步骤二中的药油混合,搅拌均匀,制成膏状,冷却后密封保存备用。
4.根据权利要求1所述的中药组合物在制备治疗气滞血瘀型骨关节炎药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202411445371.0A CN119236005A (zh) | 2024-10-16 | 2024-10-16 | 一种治疗骨关节炎的中药组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202411445371.0A CN119236005A (zh) | 2024-10-16 | 2024-10-16 | 一种治疗骨关节炎的中药组合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN119236005A true CN119236005A (zh) | 2025-01-03 |
Family
ID=94023376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202411445371.0A Pending CN119236005A (zh) | 2024-10-16 | 2024-10-16 | 一种治疗骨关节炎的中药组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN119236005A (zh) |
-
2024
- 2024-10-16 CN CN202411445371.0A patent/CN119236005A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102319350B (zh) | 一种用于治疗烧、烫伤的外用烫伤油药物组合物 | |
CN103656372B (zh) | 糖尿病足软膏 | |
CN100579556C (zh) | 一种治疗中风病的中药胶囊的生产方法 | |
CN113144062B (zh) | 一种用于治疗类风湿关节炎的药物组合物及其制备方法和用途 | |
CN107854683A (zh) | 一种治疗湿热痹阻型膝骨关节炎的膏药 | |
CN101327280B (zh) | 治疗痹症的中药 | |
CN100333763C (zh) | 褥疮生肌膏制备方法 | |
CN104689132A (zh) | 一种治疗银屑病的中药组合物 | |
CN119236005A (zh) | 一种治疗骨关节炎的中药组合物及其应用 | |
CN115252691A (zh) | 一种用于治疗气滞血瘀型冠心病心绞痛的中药组合物 | |
CN104056231B (zh) | 一种配合西医治疗老年性皮肤瘙痒症的中药组合物 | |
CN100368003C (zh) | 治疗痈、疖的药物 | |
CN107998235B (zh) | 治疗踝关节扭伤的复方壮药物及其制备方法 | |
CN104840839A (zh) | 治疗腱鞘炎的中药外洗剂及制法 | |
CN1261123C (zh) | 一种治疗巴氏囊肿、疖、疔、疮、痈的中药制剂 | |
CN116036168B (zh) | 一种用于治疗静脉炎的中药组合物及其应用 | |
CN102861195B (zh) | 一种治疗风湿疼痛的药物组合物 | |
CN107158322A (zh) | 一种用于痛风、软组织损伤、风湿疼痛的制剂及其制备方法 | |
CN111450222A (zh) | 一种治疗湿热内蕴型膝关节滑膜炎的外用中药组合物及其散剂和散剂的制备方法及使用方法 | |
CN105617214A (zh) | 一种治疗疥疮的中药组合物 | |
CN106620158A (zh) | 一种治疗银屑病的药物组合物及其制备方法 | |
CN119679879A (zh) | 一种治疗乳腺癌术后上肢淋巴水肿的中药组合物及其应用 | |
CN118453799A (zh) | 一种治疗膝滑膜炎的中药组合物及其制备方法 | |
CN105412417A (zh) | 一种治疗腱鞘炎的中药软膏及其制备方法 | |
CN119424585A (zh) | 一种退胎黄的中药外敷贴剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |